- Home
- CPRX vs ADX Comparison
CPRX vs ADX Comparison
Compare CPRX & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- ADX
- Stock Information
- Founded
- CPRX 2002
- ADX 1840
- Country
- CPRX United States
- ADX United States
- Employees
- CPRX N/A
- ADX N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- ADX Investment Managers
- Sector
- CPRX Health Care
- ADX Finance
- Exchange
- CPRX Nasdaq
- ADX Nasdaq
- Market Cap
- CPRX 2.6B
- ADX 2.3B
- IPO Year
- CPRX 2006
- ADX N/A
- Fundamental
- Price
- CPRX $24.69
- ADX $18.93
- Analyst Decision
- CPRX Strong Buy
- ADX
- Analyst Count
- CPRX 8
- ADX 0
- Target Price
- CPRX $32.50
- ADX N/A
- AVG Volume (30 Days)
- CPRX 1.5M
- ADX 182.4K
- Earning Date
- CPRX 05-07-2025
- ADX 01-01-0001
- Dividend Yield
- CPRX N/A
- ADX 6.68%
- EPS Growth
- CPRX 107.94
- ADX N/A
- EPS
- CPRX 1.31
- ADX N/A
- Revenue
- CPRX $491,734,000.00
- ADX N/A
- Revenue This Year
- CPRX $15.17
- ADX N/A
- Revenue Next Year
- CPRX $8.28
- ADX N/A
- P/E Ratio
- CPRX $18.96
- ADX N/A
- Revenue Growth
- CPRX 23.49
- ADX N/A
- 52 Week Low
- CPRX $14.47
- ADX $14.94
- 52 Week High
- CPRX $26.16
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- CPRX 62.78
- ADX 38.20
- Support Level
- CPRX $20.68
- ADX $18.86
- Resistance Level
- CPRX $26.16
- ADX $19.52
- Average True Range (ATR)
- CPRX 0.83
- ADX 0.30
- MACD
- CPRX 0.36
- ADX 0.06
- Stochastic Oscillator
- CPRX 75.21
- ADX 39.18
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.